activate tumor-specific T-cells, increase the accumulation of CD8+ T-cells within melanoma and bladder tumors, and enhance IFN-γ production, which could slow down the growth of cancer cells by downregulating the NF-kB signaling pathway [92,93]. The gene discussed is IFNG; the disease is neoplasm.